Aura Biosciences, Inc. (AURA) Net income 2020–2025
Aura Biosciences, Inc. (AURA) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$106.2MFY2025 · since FY2020: -$22.2M → -$106.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$106.2M | -22.2% |
| FY2024 | -$86.9M | -13.8% |
| FY2023 | -$76.4M | -30.0% |
| FY2022 | -$58.8M | -66.7% |
| FY2021 | -$35.3M | -58.7% |
| FY2020 | -$22.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AURA financial trends
AURA RevenueAURA Net marginAURA Gross profitAURA Gross marginAURA Operating incomeAURA Operating marginAURA Operating cash flowAURA Free cash flowAURA Capital expendituresAURA Return on equityAURA Stock buybacksAURA Dividends paidAURA Total assetsAURA Total liabilitiesAURA Shareholders’ equityAURA overview →